Published in Arch Biochem Biophys on November 01, 2003
Protein carbonylation, cellular dysfunction, and disease progression. J Cell Mol Med (2006) 2.59
Diabetic neuropathy: mechanisms to management. Pharmacol Ther (2008) 2.57
Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors. Br J Pharmacol (2007) 1.90
The aldo-keto reductase superfamily and its role in drug metabolism and detoxification. Drug Metab Rev (2008) 1.80
Advanced glycation end products in extracellular matrix proteins contribute to the failure of sensory nerve regeneration in diabetes. Diabetes (2009) 1.24
Chelation: a fundamental mechanism of action of AGE inhibitors, AGE breakers, and other inhibitors of diabetes complications. Diabetes (2012) 1.24
Dietary advanced glycation end products and aging. Nutrients (2010) 1.16
The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes. Cardiovasc Diabetol (2008) 1.16
Role of advanced glycation end products with oxidative stress in resistance artery dysfunction in type 2 diabetic mice. Arterioscler Thromb Vasc Biol (2008) 1.10
Systems biology of kidney diseases. Kidney Int (2011) 1.05
Diabetic nephropathy - complications and treatment. Int J Nephrol Renovasc Dis (2014) 1.01
Suppression of retinal neovascularization by the iNOS inhibitor aminoguanidine in mice of oxygen-induced retinopathy. Graefes Arch Clin Exp Ophthalmol (2009) 0.99
Endotoxin mediated-iNOS induction causes insulin resistance via ONOO⁻ induced tyrosine nitration of IRS-1 in skeletal muscle. PLoS One (2010) 0.99
Management of limited joint mobility in diabetic patients. Diabetes Metab Syndr Obes (2013) 0.96
Sub-antimicrobial doxycycline for periodontitis reduces hemoglobin A1c in subjects with type 2 diabetes: a pilot study. Pharmacol Res (2011) 0.95
Age-related vascular stiffening: causes and consequences. Front Genet (2015) 0.93
Antioxidant, antiglycation and cytotoxicity evaluation of selected medicinal plants of the Mascarene Islands. BMC Complement Altern Med (2012) 0.92
Current concepts in targeted therapies for the pathophysiology of diabetic microvascular complications. Vasc Health Risk Manag (2007) 0.92
Inhibition of advanced glycation end products by red grape skin extract and its antioxidant activity. BMC Complement Altern Med (2013) 0.91
Glycation free adduct accumulation in renal disease: the new AGE. Pediatr Nephrol (2005) 0.91
Inhibitory effect of metformin and pyridoxamine in the formation of early, intermediate and advanced glycation end-products. PLoS One (2013) 0.90
Imidazopurinones are markers of physiological genomic damage linked to DNA instability and glyoxalase 1-associated tumour multidrug resistance. Nucleic Acids Res (2010) 0.89
Cinnamic acid and its derivatives inhibit fructose-mediated protein glycation. Int J Mol Sci (2012) 0.88
KIOM-79, an Inhibitor of AGEs-Protein Cross-linking, Prevents Progression of Nephropathy in Zucker Diabetic Fatty Rats. Evid Based Complement Alternat Med (2011) 0.88
Reduction of advanced-glycation end products levels and inhibition of RAGE signaling decreases rat vascular calcification induced by diabetes. PLoS One (2014) 0.86
Hyperglycemic oxoaldehyde, glyoxal, causes barrier dysfunction, cytoskeletal alterations, and inhibition of angiogenesis in vascular endothelial cells: aminoguanidine protection. Mol Cell Biochem (2009) 0.85
Carbonylation of myosin heavy chains in rat heart during diabetes. Biochem Pharmacol (2010) 0.85
Aminoguanidine prevents the impairment of cardiac pumping mechanics in rats with streptozotocin and nicotinamide-induced type 2 diabetes. Br J Pharmacol (2008) 0.84
Beneficial effects of aminoguanidine on skin flap survival in diabetic rats. Exp Diabetes Res (2012) 0.84
Glycation of LDL by methylglyoxal increases arterial atherogenicity: a possible contributor to increased risk of cardiovascular disease in diabetes. Diabetes (2011) 0.84
Retinylamine Benefits Early Diabetic Retinopathy in Mice. J Biol Chem (2015) 0.83
Edaravone protects against methylglyoxal-induced barrier damage in human brain endothelial cells. PLoS One (2014) 0.81
Aminoguanidine impedes human pancreatic tumor growth and metastasis development in nude mice. World J Gastroenterol (2009) 0.80
The production of cross-reactive autoantibodies that bind to bovine serum albumin in mice administered reducing sugars by subcutaneous injection. Cent Eur J Immunol (2015) 0.80
Aminoguanidine prevents fructose-induced deterioration in left ventricular-arterial coupling in Wistar rats. Br J Pharmacol (2007) 0.80
Aminoguanidine inhibits aortic hydrogen peroxide production, VSMC NOX activity and hypercontractility in diabetic mice. Cardiovasc Diabetol (2009) 0.79
Apolipoprotein A-I glycation by glucose and reactive aldehydes alters phospholipid affinity but not cholesterol export from lipid-laden macrophages. PLoS One (2013) 0.79
A global perspective of the genetic basis for carbonyl stress resistance. G3 (Bethesda) (2011) 0.78
Combination of Medicinal Herbs KIOM-79 Reduces Advanced Glycation End Product Accumulation and the Expression of Inflammatory Factors in the Aorta of Zucker Diabetic Fatty Rats. Evid Based Complement Alternat Med (2011) 0.78
DFT study of the mechanism of the reaction of aminoguanidine with methylglyoxal. J Mol Model (2014) 0.78
Prevention of non-enzymatic glycosylation (glycation): Implication in the treatment of diabetic complication. Int J Health Sci (Qassim) (2016) 0.78
Oxidized LDL and Fructosamine Associated with Severity of Coronary Artery Atherosclerosis in Insulin Resistant Pigs Fed a High Fat/High NaCl Diet. PLoS One (2015) 0.78
New Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain. Neuron (2017) 0.77
Malondialdehyde and 4-hydroxynonenal adducts are not formed on cardiac ryanodine receptor (RyR2) and sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA2) in diabetes. Mol Cell Biochem (2013) 0.77
The action of aminoguanidine on the liver of trained diabetic rats. J Diabetes Metab Disord (2013) 0.77
Antiglycation Activity of Iridoids and Their Food Sources. Int J Food Sci (2014) 0.77
The protective effects of pomelo extract (Citrus grandis L. Osbeck) against fructose-mediated protein oxidation and glycation. EXCLI J (2013) 0.77
Diabetic Kidney Disease: Pathophysiology and Therapeutic Targets. J Diabetes Res (2015) 0.77
Resorcylidene aminoguanidine (RAG) improves cardiac mitochondrial bioenergetics impaired by hyperglycaemia in a model of experimental diabetes. Int J Mol Sci (2011) 0.76
Inhibitory effect of gold nanoparticles on the D-ribose glycation of bovine serum albumin. Int J Nanomedicine (2014) 0.76
Glycative Stress and Its Defense Machinery Glyoxalase 1 in Renal Pathogenesis. Int J Mol Sci (2017) 0.76
Targeting advanced glycation with pharmaceutical agents: where are we now? Glycoconj J (2016) 0.76
OSSC1E-K19, a novel phytochemical component of Osteomeles schwerinae, prevents glycated albumin-induced retinal vascular injury in rats. Mol Med Rep (2015) 0.75
In vitro inhibitory activities of selected Australian medicinal plant extracts against protein glycation, angiotensin converting enzyme (ACE) and digestive enzymes linked to type II diabetes. BMC Complement Altern Med (2016) 0.75
Low-molecular-weight chitosan scavenges methylglyoxal and N (ε)-(carboxyethyl)lysine, the major factors contributing to the pathogenesis of nephropathy. Springerplus (2015) 0.75
Preconditioning L6 Muscle Cells with Naringin Ameliorates Oxidative Stress and Increases Glucose Uptake. PLoS One (2015) 0.75
Inhibitory actions of selected natural substances on formation of advanced glycation endproducts and advanced oxidation protein products. BMC Complement Altern Med (2016) 0.75
Inhibitory effect of Clitoria ternatea flower petal extract on fructose-induced protein glycation and oxidation-dependent damages to albumin in vitro. BMC Complement Altern Med (2015) 0.75
Limited joint mobility syndrome in diabetes mellitus: A minireview. World J Diabetes (2015) 0.75
Crystal structure of bis-{4-bromo-2-[(carb-amim-id-amido-imino)-meth-yl]phenolato-κ(3) N,N',O}cobalt(III) nitrate di-methyl-formamide monosolvate. Acta Crystallogr E Crystallogr Commun (2016) 0.75
The ethyl acetate fraction of corn silk exhibits dual antioxidant and anti-glycation activities and protects insulin-secreting cells from glucotoxicity. BMC Complement Altern Med (2016) 0.75
Aminoguanidine partially prevents the reduction in liver pyruvate kinase activity in diabetic rats. Adv Biomed Res (2014) 0.75
The pecking order of skin Advanced Glycation Endproducts (AGEs) as long-term markers of glycemic damage and risk factors for micro- and subclinical macrovascular disease progression in Type 1 diabetes. Glycoconj J (2016) 0.75
Glucitol-core containing gallotannins inhibit the formation of advanced glycation end-products mediated by their antioxidant potential. Food Funct (2016) 0.75
Chitosan Prevents Gentamicin-Induced Nephrotoxicity via a Carbonyl Stress-Dependent Pathway. Biomed Res Int (2015) 0.75
Nutritional supplements modulate fluorescent protein-bound advanced glycation endproducts and digestive enzymes related to type 2 diabetes mellitus. BMC Complement Altern Med (2016) 0.75
Pectin lyase-modified red ginseng extract exhibits potent anti-glycation effects in vitro and in vivo. J Exerc Nutrition Biochem (2017) 0.75
Antiglycation, radical scavenging, and semicarbazide-sensitive amine oxidase inhibitory activities of acetohydroxamic acid in vitro. Drug Des Devel Ther (2017) 0.75
The role of glycation in the pathogenesis of aging and its prevention through herbal products and physical exercise. J Exerc Nutrition Biochem (2017) 0.75
Jakyakgamcho-tang and Its Major Component, Paeonia Lactiflora, Exhibit Potent Anti-glycation Properties. J Exerc Nutrition Biochem (2017) 0.75
Protective activity of gallic acid against glyoxal -induced renal fibrosis in experimental rats. Toxicol Rep (2015) 0.75
Effect of fermented and unfermented buckwheat flour on functional properties of gluten-free muffins. J Food Sci Technol (2017) 0.75
Effect of cranberry (Vaccinium macrocarpon) oligosaccharides on the formation of advanced glycation end-products. J Berry Res (2016) 0.75
Hormesis enables cells to handle accumulating toxic metabolites during increased energy flux. Redox Biol (2017) 0.75